Suppr超能文献

自发性胸痛、心电图无诊断意义、心肌酶正常且99m锝-甲氧基异丁基异腈定量断层显像无严重静息性心肌缺血证据患者的预后。

Prognosis in patients with spontaneous chest pain, a nondiagnostic electrocardiogram, normal cardiac enzymes, and no evidence of severe resting ischemia by quantitative technetium 99m sestamibi tomographic imaging.

作者信息

Miller T D, Christian T F, Hopfenspirger M R, Hodge D O, Hauser M F, Gibbons R J

机构信息

Department of Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, Minn 55905, USA.

出版信息

J Nucl Cardiol. 1998 Jan-Feb;5(1):64-72. doi: 10.1016/s1071-3581(98)80012-3.

Abstract

BACKGROUND

There are limited data addressing the outcome of patients with normal or near normal myocardial perfusion during chest pain at rest. The purpose of this study was to determine the prognosis of patients with spontaneous chest pain, a normal or nondiagnostic electrocardiogram, no enzymatic evidence of myocardial infarction, and no evidence of severe resting ischemia by quantitative technetium 99m (99mTc) sestamibi imaging.

METHODS

In the study, 111 patients who fulfilled the above criteria were injected with 99mTc sestamibi during resting chest pain and were followed for a median 2.7 years. Of the patients in the study group, 58% had coronary artery disease that was documented by clinical history or coronary angiography. Tomographic 99mTc perfusion images were interpreted with a quantitative threshold technique initially developed to detect severely hypoperfused myocardium. The images were also interpreted qualitatively to detect patients with milder degrees of hypoperfused myocardium.

RESULTS

During follow-up 3 patients had cardiac deaths, 5 had nonfatal myocardial infarctions, and 21 underwent revascularization procedures (13 within 3 months and 8 more than 3 months after the sestamibi study). At 3 years, survival free of cardiac death was 97%, survival free of cardiac death or myocardial infarction was 91%, and survival of cardiac death, myocardial infarction, or late revascularization was 82%. Quantitative analysis of the scans revealed that 100% of patients without fixed defects had 3-year survival free of cardiac death versus 76% of patients who had fixed defects (p < 0.001). Mild to moderate resting ischemia by qualitative interpretation of the scans was present in 20% of patients, but this did not predict outcome.

CONCLUSIONS

Patients with spontaneous chest pain and nonischemic quantitative 99mTc sestamibi images were at reasonably low risk for hard cardiac events although some patients (18%) required revascularization.

摘要

背景

关于静息胸痛时心肌灌注正常或接近正常的患者的预后数据有限。本研究的目的是确定有自发性胸痛、心电图正常或无诊断意义、无心肌梗死酶学证据且通过定量锝99m(99mTc) sestamibi成像无严重静息缺血证据的患者的预后。

方法

在本研究中,111例符合上述标准的患者在静息胸痛时注射99mTc sestamibi,并随访中位时间2.7年。研究组患者中,58%有临床病史或冠状动脉造影证实的冠状动脉疾病。断层99mTc灌注图像采用最初为检测严重灌注不足心肌而开发的定量阈值技术进行解读。图像也进行定性解读以检测心肌灌注不足程度较轻的患者。

结果

随访期间,3例患者发生心源性死亡,5例发生非致命性心肌梗死,21例接受了血运重建手术(13例在sestamibi研究后3个月内,8例在3个月后)。3年时,无心脏死亡的生存率为97%,无心脏死亡或心肌梗死的生存率为91%,无心脏死亡、心肌梗死或晚期血运重建的生存率为82%。扫描的定量分析显示,无固定缺损的患者100% 3年无心脏死亡生存率,而有固定缺损的患者为76%(p<0.001)。扫描定性解读显示20%的患者存在轻度至中度静息缺血,但这并不能预测预后。

结论

有自发性胸痛且99mTc sestamibi图像定量无缺血的患者发生严重心脏事件的风险相对较低,尽管一些患者(18%)需要血运重建。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验